Public Investigative Record · Updated 16 November 2026
What is that telehealth company actually selling you?
128 US companies will prescribe you a GLP-1 online. Some prescribe FDA-approved Wegovy or Zepbound. Others ship compounded semaglutide prepared by a 503A or 503B pharmacy: a different product with a different legal status at a fraction of the cost. Most patients never learn which one they are buying until they read the fine print or open the package.
Direct indexes: all 88 primary enforcement documents · 2026 compounding & 503A/503B pharmacy ledger · download raw CSV.
Compounded only
Prepared by a 503A/503B pharmacy, not FDA-approved. Lower cost, active FDA marketing scrutiny.
65 dossiers on file →File 02 · Manufacturer-sealedFDA-approved only
Wegovy, Zepbound, Ozempic, Mounjaro, or approved oral tablets dispensed by retail pharmacies.
19 dossiers on file →File 03 · Dual-track clinicsBoth categories
Offers both compounded and branded options at sharply different monthly rates. Check which is quoted.
44 dossiers on file →- Providers on record
- 128
- With actions on file
- 78
- Compounded only
- 65
- Monthly price span
- $19.99 to $1,199
- Primary regulatory & court filings indexed
- 88 sourced documents across 78 companies
How we check each provider by hand
Telehealth landing pages are built to obscure two things: whether the advertised price actually includes the drug, and who manufactures the vial that arrives at your door. For every dossier in this index, our desk inspects four primary sources:
- Checkout & fee separation (21 unbundled plans flagged): We walk the intake and pricing disclosures to verify whether the headline monthly rate includes medication or only buys a consultation (12 of 35 Wegovy listings advertise a membership fee while billing the drug separately at the pharmacy).
- Terms of Service & corporate entities: We open each clinic’s legal terms and privacy policy to record the operating LLC/PC, auto-renewal traps, multi-month prepay lock-ins, and 28-day vs. monthly billing cycles.
- 503A / 503B pharmacy mapping (34 facilities indexed): We log every compounding or fulfillment pharmacy named in pre-checkout disclosures, terms, or regulatory filings.
- Federal & state enforcement dockets (88 / 88 primary-sourced): We cross-check FDA CDER Warning Letters, PACER / CourtListener federal lawsuits (Eli Lilly, Novo Nordisk, DOJ/FTC), state boards of pharmacy, and NAD case reports.
Long-form provider files
Full price tables, terms and records
Every plan length, the refund and cancellation terms, named pharmacies, review-site links and each regulatory action with its primary document. These 6 providers pay us a referral commission if you sign up through our links; ordered by lowest verified monthly price only.
| Provider file | Sema. /mo | Tirz. /mo | Actions on file | Links |
|---|---|---|---|---|
| Embody | $49 | $99 | None | Read the dossier →Embody site ↗ |
| Belle | $93 | $149 | 1 | Read the dossier →Belle site ↗ |
| PlexusDx | $99 | $129 | None | Read the dossier →PlexusDx site ↗ |
| MEDGm | $169 | $269 | None | Read the dossier →MEDGm site ↗ |
| DirectMeds | $249 | $399 | 1 | Read the dossier →DirectMeds site ↗ |
| GoodLife Health | $299 membership | + brand-name drug | None | Read the dossier →GoodLife Health site ↗ |
- Embodyfrom $49/moSema. $49 · Tirz. $99None on file
- Bellefrom $93/moSema. $93 · Tirz. $1491 on file
- PlexusDxfrom $99/moSema. $99 · Tirz. $129None on file
- MEDGmfrom $169/moSema. $169 · Tirz. $269None on file
- DirectMedsfrom $249/moSema. $249 · Tirz. $3991 on file
- GoodLife Healthfrom $299/mo + drugMembership; brand-name drug billed separatelyNone on file
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Complete index · 128 providers
The public record
Search any company by name or filter by supply category. Every price shown is the lowest recurring or starting figure published by the provider itself. Open the dossier before comparing two numbers: a $19.99 compounded plan and a $1,199 branded programme are not the same transaction.
- 24hrdocCompounded$129/mo
- AgelessRxCompounded · medication included$99/mo
- AlanBoth · medication included$125/mo
- AlloyBoth · medication included$169/mo
- Altru TelehealthCompounded · medication included$289/mo
- altRxBoth · medication included$199/mo
- AM RxBoth · medication included$151/mo
- Amble HealthCompounded · medication included$179/mo
- AmieBoth · medication included$151/mo
- BelleCompounded · medication included$93/mo
- BioverseBoth · medication included$129/mo
- BlivCompounded · medication included$116/mo
- BluefitMDNo GLP-1No GLP-1
- bmiMDCompounded · medication included$99/mo
- Bodybuilding Health+Compounded · medication included$141.50/mo
- CalibrateFDA-approved · medication separate$199/mo
- Clover MedsCompounded · medication included$77/mo
- Cora HealthCompounded · medication included$99/mo
- CoreAge RxCompounded · medication includedNot verified
- CurexCompounded · medication included$199/mo
Each row has two links: “Read the dossier” opens our file on that provider, and the “site ↗” button opens the provider’s own site in a new tab. Nothing else in the row is a link. Where a provider runs an affiliate programme with us, its site button is a referral link and we may earn a commission at no cost to you. It never changes the order or what is on file.
Showing 20 of 128 providers. “On file” counts sourced regulatory or legal actions, not complaints.
Regulatory & court docket
Providers with the most actions on file
Ordered by the number of primary-sourced regulatory actions, federal lawsuits, or FDA warning letters on record. Every entry links directly to the underlying government or court filing on the provider’s dossier page.
Side-by-side dossiers
Head-to-head comparisons
Direct ledger comparisons for the providers patients most frequently weigh against one another: what each supplies, whether medication is included in the quote, and what sits on each regulatory file.
Category equivalents
Looking for a way out of one of them
Every provider supplying the same medication category, ordered strictly by published monthly cost and by the number of regulatory actions on file, never by commercial partnership.
Currently from $179/mo
Currently from $74/mo
Editorial charter
Why you can verify our work instead of trusting us
Primary documents only
Every adverse claim about a company links directly to an FDA warning letter, a federal court docket, or a regulator’s published order. Customer review sites, blogs, and affiliate roundups are never used as evidence.
No star ratings or scores
We do not rate providers out of ten. We do not operate a chemical testing lab, and a numerical score would invent a clinical precision that does not exist. You get the documented facts and the primary links.
“Nothing found” is not “clean”
Where our sweep found no regulatory action against a company, the dossier states exactly that. It is a report on the public registries we searched, not a certificate of endorsement.
Commercial links are counted
A minority of providers pay a referral commission; the majority do not, and every dossier states which is which underneath the button. The exact count is published on our disclosure page.
Reference notes
The questions behind the tenfold price gap
- What is the difference between compounded and FDA-approved GLP-1s?
- FDA-approved GLP-1s are the branded medications (Wegovy, Zepbound, Ozempic, Mounjaro, and the approved oral versions) reviewed by the FDA for safety, manufacturing consistency, and clinical effectiveness. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not FDA-approved products. Compounding is legal under specific statutory conditions, and it is also the category targeted by more than 80 FDA warning letters since September 2025. Compounded formulations are substantially cheaper, which explains why advertised monthly prices span from $19.99 to $1,199.
- Which providers have regulatory actions against them?
- 78 of the 128 companies in this database have at least one sourced regulatory or legal action on file (88 actions in total). Every action is indexed with a direct link to the primary document on the enforcement ledger.
- Does an FDA warning letter mean a company is a fake storefront?
- No. Most FDA warning letters issued to telehealth brands since late 2025 address how a compounded drug was advertised on a website (for example, calling a compounded vial “generic Ozempic” or claiming equivalence to an approved product), not whether the business exists or ships orders. That distinction is why we summarize the specific allegation and link the original letter rather than issuing a blanket pass/fail grade.
- Is this database free to use and cite?
- Yes. Both the web dossiers and the underlying CSV/JSON files (providers.csv and actions.csv) are published free of charge under a Creative Commons CC BY 4.0 license. A minority of providers pay an affiliate commission if you sign up through their link, and those pages state so plainly.